The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $935,174 in first-year total cost, median $256,925.
Most frequent study sections
- Drug Discovery for the Nervous System Study Section[DDNS]3
Most frequent institutions
- UNIV OF NORTH CAROLINA CHAPEL HILL1
- UNIVERSITY OF ILLINOIS AT CHICAGO1
- UNIVERSITY OF NORTH TEXAS HLTH SCI CTR1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Discovery of small molecule activators of the Slack potassium channel for use as cell-based probes for the study of fragile X syndrome1R21MH125257-01 | EMMITTE, KYLE AWEAVER, C DAVID | UNIVERSITY OF NORTH TEXAS HLTH SCI CTR, TX | $238,524 | DDNS |
| 2020 | Selective targeting pathological tau signaling in AD and related dementia1R21AG067772-01A1 | BRADY, SCOTT THOMAS | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $439,725 | DDNS |
| 2019 | Designing and developing PAM-antagonists for GPR681R21MH120422-01 | HUANG, XI-PINGKENAKIN, TERRENCE PETER | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $256,925 | DDNS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.